{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T02:16:02Z","timestamp":1793153762241,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Netherlands Ministry of Health Welfare and Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Regional Health - Europe"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.lanepe.2021.100142","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T07:25:41Z","timestamp":1622100341000},"page":"100142","source":"Crossref","is-referenced-by-count":76,"special_numbering":"C","title":["Prevalence of persistent symptoms after treatment for lyme borreliosis: A prospective observational cohort study"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-5165","authenticated-orcid":false,"given":"Jeanine","family":"Ursinus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hedwig D.","family":"Vrijmoeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margriet G.","family":"Harms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna D.","family":"Tulen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie A.","family":"Gauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tizza P.","family":"Zomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid H.M.","family":"Friesema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande M.","family":"Vermeeren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo A.B.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joppe W.","family":"Hovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart Jan","family":"Kullberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cees C.","family":"van den Wijngaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lanepe.2021.100142_bib0001","article-title":"Long-term sequelae and health-related quality-of-life associated with lyme disease: a systematic review","author":"Mac","year":"2019","journal-title":"Clin Infect Dis: An Off Pub Of The Infect Dis Soc of Am"},{"issue":"9","key":"10.1016\/j.lanepe.2021.100142_bib0002","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the infectious diseases society of america","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lanepe.2021.100142_bib0003","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s13071-015-0777-6","article-title":"Physician reported incidence of early and late lyme borreliosis","volume":"8","author":"Hofhuis","year":"2015","journal-title":"Paras Vect"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100142_bib0004","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early lyme disease","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"issue":"12","key":"10.1016\/j.lanepe.2021.100142_bib0005","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1093\/cid\/civ735","article-title":"Long-term assessment of post-treatment symptoms in patients with culture-confirmed early lyme disease","volume":"61","author":"Weitzner","year":"2015","journal-title":"Clin Infects Dis: An Off Pub Of The Infect Dis Soc of Am"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100142_bib0006","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","article-title":"European neuroborreliosis: quality of life 30 months after treatment","volume":"124","author":"Eikeland","year":"2011","journal-title":"Acta Neurol Scand"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100142_bib0007","first-page":"e443","article-title":"Development of a foundation for a case definition of post-treatment lyme disease syndrome","volume":"17","author":"Aucott","year":"2013","journal-title":"Int J Of Infect Dis: IJID: Off Pub Of The Int Soc For Infect Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100142_bib0008","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00415-015-7923-0","article-title":"Prevalence and spectrum of residual symptoms in lyme neuroborreliosis after pharmacological treatment: a systematic review","volume":"263","author":"Dersch","year":"2016","journal-title":"J Neurol"},{"key":"10.1016\/j.lanepe.2021.100142_bib0009","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/ciz1215","article-title":"Prospective evaluation of the frequency and severity of symptoms in lyme disease patients with erythema migrans compared with matched controls at baseline, 6 months, and 12 months","author":"Wormser","year":"2020","journal-title":"Clin Infect Dis: An Off Pub Of The Inf Dis Soc of Am"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100142_bib0010","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","article-title":"Remaining complaints 1 year after treatment for acute lyme neuroborreliosis; frequency, pattern and risk factors","volume":"17","author":"Ljostad","year":"2010","journal-title":"Eur J Neurol"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100142_bib0011","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjmed.2014.09.022","article-title":"Long-term assessment of fatigue in patients with culture-confirmed lyme disease","volume":"128","author":"Wormser","year":"2015","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100142_bib0012","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1086\/318082","article-title":"Evaluation of study patients with lyme disease, 10-20-year follow-up","volume":"183","author":"Kalish","year":"2001","journal-title":"J Infect Dis"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100142_bib0013","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.amjmed.2017.11.050","article-title":"Straight talk about chronic lyme disease","volume":"131","author":"Baker","year":"2018","journal-title":"Am J Med"},{"issue":"13","key":"10.1016\/j.lanepe.2021.100142_bib0014","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized trial of longer-term therapy for symptoms attributed to lyme disease","volume":"374","author":"Berende","year":"2016","journal-title":"The New Eng J Of Medi"},{"key":"10.1016\/j.lanepe.2021.100142_bib0015","doi-asserted-by":"crossref","first-page":"m1041","DOI":"10.1136\/bmj.m1041","article-title":"Lyme borreliosis: diagnosis and management","volume":"369","author":"Kullberg","year":"2020","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100142_bib0016","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12879-019-3949-8","article-title":"Prevalence and determinants of persistent symptoms after treatment for lyme borreliosis: study protocol for an observational, prospective cohort study (lymeprospect)","volume":"19","author":"Vrijmoeth","year":"2019","journal-title":"BMC Infect Dis"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100142_bib0017","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/0022-3999(94)90099-X","article-title":"Dimensional assessment of chronic fatigue syndrome","volume":"38","author":"Vercoulen","year":"1994","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.lanepe.2021.100142_bib0018","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jpsychores.2017.05.007","article-title":"The assessment of fatigue: psychometric qualities and norms for the Checklist individual strength","volume":"98","author":"Worm-Smeitink","year":"2017","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.lanepe.2021.100142_bib0019","first-page":"131","article-title":"De checklist individual strength (CIS)","volume":"32","author":"Vercoulen","year":"1999","journal-title":"Gedragstherapie"},{"key":"10.1016\/j.lanepe.2021.100142_bib0020","first-page":"37","article-title":"De cognitive failure questionnaire als maat voor subjectief cognitief functioneren","volume":"2","author":"Ponds","year":"2006","journal-title":"Tijdschrift voor Neuropsychologie"},{"issue":"2","key":"10.1016\/j.lanepe.2021.100142_bib0021","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1207\/s15327558ijbm0302_2","article-title":"Psychometric qualities of the RAND 36-Item Health Survey 1.0: a multidimensional measure of general health status","volume":"3","author":"VanderZee","year":"1996","journal-title":"Int J Behav Med"},{"issue":"11","key":"10.1016\/j.lanepe.2021.100142_bib0022","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/S0895-4356(98)00097-3","article-title":"Translation, validation, and norming of the Dutch language version of the SF-36 Health Survey in community and chronic disease populations","volume":"51","author":"Aaronson","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.lanepe.2021.100142_bib0023","series-title":"Het meten van de algemene gezondheidstoestand met de RAND-36, een handleiding: umcg \/Rijksuniversiteit groningen","author":"van der Zee","year":"2012"},{"issue":"7","key":"10.1016\/j.lanepe.2021.100142_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0181807","article-title":"Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model","volume":"12","author":"Hofhuis","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.lanepe.2021.100142_bib0025","series-title":"Fatigue in patients with chronic disease: towards a trans-diagnostic risk prediction model","author":"Go\u00ebrtz","year":"2021"},{"issue":"5","key":"10.1016\/j.lanepe.2021.100142_bib0026","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155884","article-title":"Fatigue following Acute Q-Fever: a Systematic Literature Review","volume":"11","author":"Morroy","year":"2016","journal-title":"PLoS ONE"},{"issue":"7568","key":"10.1016\/j.lanepe.2021.100142_bib0027","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bmj.38933.585764.AE","article-title":"Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study","volume":"333","author":"Hickie","year":"2006","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.lanepe.2021.100142_bib0028","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1037\/hea0000598","article-title":"Is fatigue a disease-specific or generic symptom in chronic medical conditions?","volume":"37","author":"Menting","year":"2018","journal-title":"Health Psychol"},{"issue":"10270","key":"10.1016\/j.lanepe.2021.100142_bib0029","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100142_bib0030","doi-asserted-by":"crossref","first-page":"e18220","DOI":"10.1371\/journal.pone.0018220","article-title":"Decreased Th1-type inflammatory cytokine expression in the skin is associated with persisting symptoms after treatment of erythema migrans","volume":"6","author":"Sjowall","year":"2011","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.lanepe.2021.100142_bib0031","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1007\/s00415-015-7891-4","article-title":"Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis","volume":"262","author":"Dersch","year":"2015","journal-title":"J Neurol"},{"issue":"3","key":"10.1016\/j.lanepe.2021.100142_bib0032","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Diss: An Off Pub Of The Infect Dis Soc of Am"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100142_bib0033","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in europe","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol And Infect: The Off Pub Of The Euro Soc Of Clin Microbiol And Infect Dis"},{"issue":"1","key":"10.1016\/j.lanepe.2021.100142_bib0034","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1186\/s12879-019-4452-y","article-title":"Cognitive impairments in patients with persistent symptoms attributed to Lyme disease","volume":"19","author":"Berende","year":"2019","journal-title":"BMC Infect Dis"}],"updated-by":[{"DOI":"10.1016\/j.lanepe.2023.100622","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000}}],"container-title":["The Lancet Regional Health - Europe"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221001198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666776221001198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T17:39:28Z","timestamp":1653241168000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666776221001198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":34,"alternative-id":["S2666776221001198"],"URL":"https:\/\/doi.org\/10.1016\/j.lanepe.2021.100142","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.lanepe.2023.100622","asserted-by":"object"}]},"ISSN":["2666-7762"],"issn-type":[{"value":"2666-7762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"article-number":"100142"}}